Over-expression of neuroepithelial-transforming protein 1 confers poor prognosis of patients with Gliomas

Japanese Journal of Clinical Oncology

Volumn 40, Issue 5, 2010, Pages 388-394

  Tu, Yanyang ^a   Lu, Jiang ^a   Fu, Jianfang ^b   Cao, Yizhan ^a   Fu, Guoqiang ^a   Kang, Ruirui ^a   Tian, Xiaoxi ^a   Wang, Boliang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Neuroepithelial transforming protein 1; Prognosis

Indexed keywords

NEUROEPITHELIAL TRANSFORMING PROTEIN 1; PROTEIN ANTIBODY; TRANSFORMING PROTEIN; UNCLASSIFIED DRUG; NET1 PROTEIN, HUMAN; ONCOPROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE OVEREXPRESSION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MALE; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR BIOPSY; BRAIN TUMOR; CASE CONTROL STUDY; CHINA; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; SURVIVAL;

BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHINA; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOGENE PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77952576092     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyp186     Document Type: Article

References (20)

1. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000;88:2887.
2. Noble M, Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci 2004;27:148-54.
3. Uematsu M, Ohsawa I, Aokage T, Nishimaki K, Matsumoto K, Takahashi H, et al. Prognostic significance of the immunohistochemical index of survivin in glioma: a comparative study with the MIB-1 index. J Neurooncol 2005;72:231-8.
4. Chen L, Li XY, Wang Y, Zhu YY, Zhu JW. Expression and significance of NET-1 protein in hepatocellular carcinoma. Zhonghua Zhong Liu Za Zhi 2007;29:917-21 (in Chinese).
5. Symons M, Rusk N. Control of vesicular trafficking by Rho GTPases. Curr Biol 2003;13:R409-18.
6. Rossman KL, Der CJ, Sondek J. GEF meansgo: turningon RHO GT Pases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005;6:167-80.
7. Leyden J, Murray D, Moss A, Arumuguma M, Doyle E, McEntee G, et al. Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer 2006;94:1204-12.
8. Murray D, Horgan G, MacMathuna P, Doran P. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer. Br J Cancer 2008;99:1322-9.
9. Shen S-Q, Li K, Zhu N, Nakao A. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol 2008;25:341-5.
10. Chen L, Wang Z, Zhan X, Li D-C, Zhu Y-Y, Zhu J. Association of NET-1 gene expression with human hepatocellular carcinoma. Int J Surg Pathol 2007;15:346-53.
11. Chakravarti A, Noll E, Black PM. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol 2002;20:1063-8.
12. Kajiwara Y, Yamasaki F, Hama S. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Cancer 2003;97:1077-83.
13. Caldas H, Jiang Y, Holloway MP. Survivin splice variants regulate the balance between proliferation and cell death. Oncogene 2005;24: 1994-2007.
14. Wollscheid V, Kuhne-Heid R, Stein I. Identification of a new proliferation-associated protein net-1/c4-8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer 2002;99:771-5.
15. Qin H, Carr HS, Wu X, Muallem D, Tran NH, Frost JA. Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1. J Biol Chem 2005;280:7603-13
16. Ellis S, Mellor H. The novel Rho-family GTPase rif regulates coordinated actin-based membrane rearrangements. Curr Biol 2000;10:1387-90.
17. Evers EE, Zondag GC, Malliri A, Price LS, ten Klooster JP, van der Kammen RA, et al. Rho family proteins in cell adhesion and cell migration. Eur J Cancer 2000;36:1269-74.
18. Yauch RL, Hemler ME. Specific interactions among transmembrane 4 superfamily (TM4SF) proteins and phosphoinositide 4-kinase. Biochem J 2000;351:629-37.
19. Serru V, Dessen P, Boucheix C, Rubinstein E. Sequence and expression of seven new tetraspans. Biochim Biophys Acta 2000;1478:159-63.
20. Wollscheid V, Kühne-Heid R, Stein I, Jansen L, Köllner S, Schneider A, et al. Identification of a new proliferation-associated protein net-1/c4.8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinomas. Int. J. Cancer 2002;99:771-5.